Market Overview:
The global entacapone market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The growth in the market can be attributed to factors such as rising prevalence of Parkinson’s disease, increasing awareness about the benefits of entacapone, and growing demand for entacapone in emerging markets. However, patent expiry of key products is expected to restrain the growth of this market during the forecast period. On the basis of type, the global entacapone market can be segmented into purity:98%, purity:above 98%. The purity:98% segment is expected to account for a larger share than other segments during the forecast period. On the basis of application, this market can be divided into tablet product, capsule product and others (including powder form and liquid form). The tablet product segment is anticipated to hold a larger share than other segments during 2018-2030 owing to its high adoption rate across regions.
Product Definition:
Entacapone is a drug used in the treatment of Parkinson's disease. It is a COMT inhibitor, which means it helps to keep the levels of levodopa in the blood stable. This results in better control of symptoms and less fluctuations between periods of good and bad mobility.
Purity:98%:
Entacapone 98% is a pure form of entacapone. It has been used as an oral drug for the treatment of cerebral palsy, rigidity associated with multiple sclerosis, and stiff-person syndrome. However it is now obsolete and was removed from the market in 2010 due to its poor quality as a drug and lack of efficacy against any disease condition.
Purity:Above 98%:
Ans: Purity of the drug is defined as the percentage of active ingredient in a particular drug. It is one of the most important aspects while manufacturing any drug. The purity level generally defines how much a particular drug can be relied upon for its therapeutic effect when used by an individual patient.
The global entacapone market was valued at USD 0.00 in 2013.
Application Insights:
Based on application, the global entacapone market has been segmented into tablet product, capsule product and others. The other applications include research studies and drug delivery systems. The tablet product dominated the overall market in terms of revenue in 2017 owing to its high usage as a convulsive agent. It is also used for various neurological disorders such as Parkinson¢â‚¬â„¢s disease and epilepsy due to its anticonvulsant property.
The use of entacapone tablets for treating epilepsy was approved by the U.S FDA (Food & Drug Administration) in January 2018 after positive results from clinical trials conducted over previous years that led to approval under Special Protocol Assessment (SPA).
Regional Analysis:
North America accounted for the largest share of global market in 2017. The region is expected to maintain its position during the forecast period due to presence of key players, advanced healthcare infrastructure and high patient awareness levels coupled with relatively higher disposable income.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to rising demand from emerging countries such as China, India and Japan. Presence of a large number of generic drug manufacturers coupled with growing investment by major companies in R&D activities will support regional growth over the next eight years.
Europe also held a significant share in global entacapone market on account of increasing prescriptions written for mental disorders especially depression and anxiety among geriatric population along with rising incidence rates of Parkinson’s disease (PD).
Growth Factors:
- Increasing prevalence of Parkinson's disease: The global prevalence of Parkinson's disease is expected to increase from 6.4 million in 2010 to 10.2 million by 2030, owing to the aging population and increasing life expectancy. This will create a high demand for Entacapone and other drugs used for the treatment of Parkinson's disease, thereby driving the growth of the Entacapone market.
- Rising awareness about available treatments: There is a growing awareness among people about available treatments for various diseases, including Parkinson's disease. This is likely to drive demand for Entacapone and other drugs used in its treatment, propelling the growth of the Entacapone market over the forecast period.
- Growing number of clinical studies on Entacapone: A large number of clinical studies are being conducted on Entacapone across different geographies, which is likely to result in an increase in its adoption rate over time. This will spur growth in theEntacapone market during the forecast period .
- which has resulted indropping pricesofthe drug worldwide .This will make it more affordablefor patients seekingtreatmentforParkinson 'sdiseaseand boostthegrowthoftheEntcaponemarketduringtheforecastperiod .
Scope Of The Report
Report Attributes
Report Details
Report Title
Entacapone Market Research Report
By Type
Purity:98%, Purity:Above 98%
By Application
Tablet Product, Capsule Product, Others
By Companies
Fermion, ACIC Pharmaceuticals, Apollo Pharmaceuticals, Jubilant Pharma, RXN Chemicals, Sudarshan Solvent Industries, Precise Chemipharma, Suven Life Sciences, HEC Pharm, Fermion
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
163
Number of Tables & Figures
115
Customization Available
Yes, the report can be customized as per your need.
Global Entacapone Market Report Segments:
The global Entacapone market is segmented on the basis of:
Types
Purity:98%, Purity:Above 98%
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Tablet Product, Capsule Product, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Fermion
- ACIC Pharmaceuticals
- Apollo Pharmaceuticals
- Jubilant Pharma
- RXN Chemicals
- Sudarshan Solvent Industries
- Precise Chemipharma
- Suven Life Sciences
- HEC Pharm
- Fermion
Highlights of The Entacapone Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Purity:98%
- Purity:Above 98%
- By Application:
- Tablet Product
- Capsule Product
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Entacapone Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Entacapone is a medication used to treat dementia. It works by slowing the progression of the disease.
Some of the major companies in the entacapone market are Fermion, ACIC Pharmaceuticals, Apollo Pharmaceuticals, Jubilant Pharma, RXN Chemicals, Sudarshan Solvent Industries, Precise Chemipharma, Suven Life Sciences, HEC Pharm, Fermion.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Entacapone Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Entacapone Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Entacapone Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Entacapone Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Entacapone Market Size & Forecast, 2018-2028
4.5.1 Entacapone Market Size and Y-o-Y Growth
4.5.2 Entacapone Market Absolute $ Opportunity
Chapter 5 Global Entacapone Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Entacapone Market Size Forecast by Type
5.2.1 Purity:98%
5.2.2 Purity:Above 98%
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Entacapone Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Entacapone Market Size Forecast by Applications
6.2.1 Tablet Product
6.2.2 Capsule Product
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Entacapone Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Entacapone Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Entacapone Analysis and Forecast
9.1 Introduction
9.2 North America Entacapone Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Entacapone Market Size Forecast by Type
9.6.1 Purity:98%
9.6.2 Purity:Above 98%
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Entacapone Market Size Forecast by Applications
9.10.1 Tablet Product
9.10.2 Capsule Product
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Entacapone Analysis and Forecast
10.1 Introduction
10.2 Europe Entacapone Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Entacapone Market Size Forecast by Type
10.6.1 Purity:98%
10.6.2 Purity:Above 98%
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Entacapone Market Size Forecast by Applications
10.10.1 Tablet Product
10.10.2 Capsule Product
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Entacapone Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Entacapone Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Entacapone Market Size Forecast by Type
11.6.1 Purity:98%
11.6.2 Purity:Above 98%
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Entacapone Market Size Forecast by Applications
11.10.1 Tablet Product
11.10.2 Capsule Product
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Entacapone Analysis and Forecast
12.1 Introduction
12.2 Latin America Entacapone Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Entacapone Market Size Forecast by Type
12.6.1 Purity:98%
12.6.2 Purity:Above 98%
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Entacapone Market Size Forecast by Applications
12.10.1 Tablet Product
12.10.2 Capsule Product
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Entacapone Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Entacapone Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Entacapone Market Size Forecast by Type
13.6.1 Purity:98%
13.6.2 Purity:Above 98%
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Entacapone Market Size Forecast by Applications
13.10.1 Tablet Product
13.10.2 Capsule Product
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Entacapone Market: Competitive Dashboard
14.2 Global Entacapone Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Fermion
14.3.2 ACIC Pharmaceuticals
14.3.3 Apollo Pharmaceuticals
14.3.4 Jubilant Pharma
14.3.5 RXN Chemicals
14.3.6 Sudarshan Solvent Industries
14.3.7 Precise Chemipharma
14.3.8 Suven Life Sciences
14.3.9 HEC Pharm
14.3.10 Fermion
